QUOTE AND NEWS
PR Newswire  Nov 5  Comment 
CINCINNATI, Nov. 5 /PRNewswire/ -- To most of the nation's 70 million pet owners, pets are family too. And when pets get sick or injured, many owners are willing to spend almost whatever it takes to get them back on all four feet. But the price of
Business Wire  Oct 28  Comment 
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that on October 26, 2009, the Company received notice that the Nasdaq Listing Qualifications Panel (Panel) has granted the Company’s request to transfer the listing of
Business Wire  Oct 20  Comment 
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two
Business Wire  Sep 21  Comment 
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on September 15, 2009, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock
Business Wire  Sep 15  Comment 
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product . The product,
StreetInsider.com  Jul 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/FDA+to+Review+A.P.+Pharma%27s+%28APPA%29+NDA+of+APF530+to+Treat+Chemotherapy-Induced+Nausea+and+Vomiting/4802987.html for the full story.
MarketWatch  Jul 20  Comment 
A.P. Pharma Inc. said Monday that it has received notice from the Nasdaq Stock Market that it has not regained compliance with a rule on minimum stockholders equity. The company said it intends to request a hearing at which it will present its...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
APPA AT A GLANCE
P/E -1.57 
EV/EBITDA -2.38 
ROA -120.9%LOW
ROE -183.8%LOW
Debt to Equity 2.48HIGH
Current Ratio 1.65LOW
 
 
 
 
 
 
 
 



References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki